Cardiovascular Tissue Engineering stands at the forefront of innovative approaches to address the challenges posed by cardiovascular diseases. This interdisciplinary field combines principles from biology, engineering, and materials science to develop artificial cardiovascular tissues or enhance the regenerative capacity of existing tissues. Researchers utilize biomaterials, including scaffolds and hydrogels, combined with cells and signaling molecules to create constructs that mimic the structure and function of native cardiovascular tissues. The goal is to generate functional blood vessels, heart valves, and even entire organs for transplantation. Techniques such as 3D bioprinting enable precise deposition of cells and biomaterials, facilitating the creation of complex tissue structures. Cardiovascular tissue engineering holds significant promise for personalized medicine, offering tailored solutions for patients with congenital heart defects, heart failure, or vascular disorders. While challenges like achieving optimal vascularization and integration persist, ongoing advancements in stem cell research, biomaterial development, and tissue fabrication techniques propel the field toward transformative breakthroughs in cardiovascular healthcare. The convergence of engineering and biology in cardiovascular tissue engineering represents a paradigm shift in the quest for effective and sustainable solutions to combat cardiovascular diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States